| 1) When the pregnancy was unintended (compared with when it was intended) mother |
| 2) Compared with controls, beta-thalassaemia |
| 3) Compared with controls, warfarin-treated m |
| 4) Compared with healthy participants, Chines |
| 5) Compared with healthy participants, Chines |
| 6) Compared with normal-weight women, overwei |
| 7) Compared with reference data from mildly l |
| 8) Compared with regular daytime workers, and |
| 9) Compared with the Kowa laser flare meter's |
| 10) Compared with the control, PDT promoted a |
| 11) Noodle," and "Alcohol and accompaniment." Compared with the low tertile of the "Alco |
| 12) Compared with the low-risk group, the odds |
| 13) Compared with the reference strains, there |
| 14) Compared with the rs13347CC genotype, CT c |
| 15) Compared with the unvaccinated (control) g |
| 16) Compared with their counterparts, the foll |
| 17) Compared with their unexposed counterparts |
| 18) Compared with those having neither initial |
| 19) ecies were also reported and results were compared with 10 µg/ml dose of Gentamic |
| 20) n the two dressings (14·2 days using TMD compared with 13·2 days using CMC-Ag). |
| 21) protective (6-68% less risk for 2nd birth compared with 1st and 10-73% less for ≥3 |
| 22) iferation over an 18 day culture period compared with 2% and 4% POSS-PCU (p < |
| 23) % of children in the ORT group vomited as compared with 20.7% of children in the ORT |
| 24) ne concentration (UIC) was higher in 2011 compared with 2009 for both pregnant (85 a |
| 25) lower in 2012 (0.1% = 1 per 1050 tested) compared with 2011 (0.56% = 13 per 2300 te |
| 26) uments for collecting dietary intake when compared with 24-h dietary recalls or doub |
| 27) her probability of any SHSe among Koreans compared with 6% (95% CI = 2-10) among Kor |
| 28) with diabetes achieved BP control target, compared with 60.1% patients without diabe |
| 29) stress, and physiological stress and were compared with 70 controls from the urban s |
| 30) xpression was strongly upregulated by CWF compared with AWF. |
| 31) ld lower costs and better health outcomes compared with AZT+sd-NVP. |
| 32) th lower mean cortical Aβ ligand binding compared with Alzheimer disease. |
| 33) 0.120) and Indo-European (0.060-0.076) as compared with Austro-Asiatic (0.011-0.022) |
| |